SK bioscience Co.,Ltd.

KOSE:A302440 Stock Report

Market Cap: ₩4.4t

SK bioscienceLtd Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Jae-Yong Ahn

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.8yrs
CEO ownership0.06%
Management average tenureno data
Board average tenure3.8yrs

Recent management updates

Recent updates

Is SK bioscienceLtd (KRX:302440) A Risky Investment?

Jul 11
Is SK bioscienceLtd (KRX:302440) A Risky Investment?

SK bioscienceLtd's (KRX:302440) Weak Earnings May Only Reveal A Part Of The Whole Picture

Mar 23
SK bioscienceLtd's (KRX:302440) Weak Earnings May Only Reveal A Part Of The Whole Picture

CEO

Jae-Yong Ahn (57 yo)

3.8yrs

Tenure

Mr. Jae-Yong Ahn is the Chief Executive Officer and President of SK bioscience Co.,Ltd since March 2021 and served as its Chairman since March 2021. He serves as Executive Officer and Director of VAX Busi...


Board Members

NamePositionTenureCompensationOwnership
Jae-Yong Ahn
CEO, President & Directorno datano data0.056%
₩ 2.4b
Hoon Kim
Executive Director3.8yrsno data0.056%
₩ 2.4b
Kwon Ik-Hwan
Independent Chairman of the Board3.8yrsno datano data
Moon Chang-Jin
Independent Outside Director4.2yrsno datano data
Choi Jeong-Wook
Independent Outside Director4.2yrsno datano data
JAEHYEON AHN
Non-Executive Director1.8yrsno datano data

3.8yrs

Average Tenure

Experienced Board: A302440's board of directors are considered experienced (3.8 years average tenure).